Adults switching from injectable GLP-1 drugs to Wegovy pills lost weight in study
A retrospective analysis presented at the 2026 European Association for the Study of Diabetes meeting in Milan found that adults with overweight or obesity who switched from injections to the oral semaglutide pill lost an average of 4.1 percent of their body weight over three months.









